Euro PCR 2024
Interviews from the leading cardiovascular interventional medicine event
Euro PCR 2024
Interviews from the leading cardiovascular interventional medicine event
The EuroPCR 2024 course saw the participation of a record number of 12,100 participants from all over the world, including interventional cardiologists, cardiologists, nurses and allied professionals. An important event in the field of interventional cardiovascular medicine, it is characterized by its pioneering approach to continuing education and also represents the opportunity for the presentation of cutting-edge studies by the main research groups.
The EuroPCR 2024 course saw the participation of a record number of 12,100 participants from all over the world, including interventional cardiologists, cardiologists, nurses and allied professionals. An important event in the field of interventional cardiovascular medicine, it is characterized by its pioneering approach to continuing education and also represents the opportunity for the presentation of cutting-edge studies by the main research groups.
Focus on the risks of dual antiplatelet therapy
en
Prof. Marco Valgimigli
How to personalize the antithrombotic strategy in the individual patient
it
Prof. Giulio Stefanini
Focus sui rischi della duplice terapia antiaggregante
it
Prof. Marco Valgimigli
Percutaneous treatment of coronary biforcations
en
Prof. Francesco Burzotta
Angioplasty, advances in imaging technologies
it
Prof. Giuseppe Sangiorgi
The A. Grüntzig Ethica Award for the edge to edge technique in mitral regurgitation
en
Prof. Ottavio Alfieri
CALIPSO trial: OCT guided PCI for calcified lesions
en
Dr. Nicolas Amabile
Patients at high risk of bleeding: the load of antiplatelet agents to be reduced
it
Dr. Carlo Andrea Pivato